Stopping azithromycin mass drug administration for trachoma: A systematic review.

The World Health Organization (WHO) recommends continuing azithromycin mass drug administration (MDA) for trachoma until endemic regions drop below 5% prevalence of active trachoma in children aged 1-9 years. Azithromycin targets the ocular strains of Chlamydia trachomatis that cause trachoma. Regio...

Полное описание

Библиографические подробности

Главные авторы:	Hamidah Mahmud, Emma Landskroner, Abdou Amza, Solomon Aragie, William W Godwin, Anna de Hostos Barth, Kieran S O'Brien, Thomas M Lietman, Catherine E Oldenburg
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Public Library of Science (PLoS) 2021-07-01
Серии:	PLoS Neglected Tropical Diseases
Online-ссылка:	https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0009491&type=printable
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!